Jeffrey T. Jensen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jeffrey T. Jensen has a total of 450 co-authors. Here are the top co-authors by number of shared publications:
- Alison Edelman
Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, Oregon, USA
32 shared publications Alison Edelman
Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR, United States
22 shared publicationsMark D. Nichols
Department of Obstetrics and Gynecology, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, UHN 50, Portland, OR 97239, USA
19 shared publicationsAlison B. Edelman
Oregon Health & Science University, Department of Obstetrics and Gynecology, 3181 SW Sam Jackson Park Road, UHN 50, Portland, OR 97239, USA
14 shared publications- Elizabeth Micks
Department of Obstetrics and Gynecology University of Washington Seattle Washington USA
11 shared publications Mark Nichols
Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, OR, USA
8 shared publications
Latest Publications
- Open Access
- 9 January 2023
- Published by Elsevier in Contraception
- Vol. 120, 109954
Extended use of levonorgestrel-releasing intrauterine system (LNG-IUS) 52 mg: A population pharmacokinetic approach to estimate in vivo levonorgestrel release rates and systemic exposure including comparison with two other LNG-IUSs
- 9 January 2023
- Published by Elsevier in Contraception
- Vol. 120, 109954
Open AccessExtended use of levonorgestrel-releasing intrauterine system (LNG-IUS) 52 mg: A population pharmacokinetic approach to estimate in vivo levonorgestrel release rates and systemic exposure including comparison with two other LNG-IUSs
- Open Access
- 20 October 2022
- Published by Elsevier in JVS-Vascular Science
- Vol. 3, 316-335
Systemic polidocanol from intravenous or pressurized intrauterine administration produces reversible cardiovascular toxicity
- 20 October 2022
- Published by Elsevier in JVS-Vascular Science
- Vol. 3, 316-335
Open AccessSystemic polidocanol from intravenous or pressurized intrauterine administration produces reversible cardiovascular toxicity
- Open Access
- 9 September 2022
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 227 (6) , 873.e1-873.e12
Contraceptive efficacy and safety of the 52-mg levonorgestrel intrauterine system for up to 8 years: findings from the Mirena Extension Trial
- 9 September 2022
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 227 (6) , 873.e1-873.e12
Open AccessContraceptive efficacy and safety of the 52-mg levonorgestrel intrauterine system for up to 8 years: findings from the Mirena Extension Trial
- 6 July 2022
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 140 (2) , 143-145
Why I Will Boycott Complex Family Planning Board Certification
- 6 July 2022
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 140 (2) , 143-145
Why I Will Boycott Complex Family Planning Board Certification
- 13 May 2022
- Published by Elsevier in Journal of Obstetrics and Gynaecology Canada
- Vol. 44 (5) , 602-603
Pooled Phase-3 Analysis of Efficacy and Safety of Estetrol/Drospirenone Combined Oral Contraceptive
- 13 May 2022
- Published by Elsevier in Journal of Obstetrics and Gynaecology Canada
- Vol. 44 (5) , 602-603
Pooled Phase-3 Analysis of Efficacy and Safety of Estetrol/Drospirenone Combined Oral Contraceptive
- 1 April 2022
- Published by Elsevier in Contraception
- Vol. 108, 61-64
The use of serum segesterone acetate levels to assess adherence of trial participants with a contraceptive vaginal ring
- 1 April 2022
- Published by Elsevier in Contraception
- Vol. 108, 61-64
The use of serum segesterone acetate levels to assess adherence of trial participants with a contraceptive vaginal ring
- Open Access
- 23 February 2022
- Published by Elsevier in Contraception: X
- Vol. 4, 100073
Ovulation suppression following subcutaneous administration of depot medroxyprogesterone acetate
- 23 February 2022
- Published by Elsevier in Contraception: X
- Vol. 4, 100073
Open AccessOvulation suppression following subcutaneous administration of depot medroxyprogesterone acetate
- 23 October 2021
- Published by Taylor & Francis in Accountability in Research
- Vol. 30 (6) , 343-355
OHSU Employees’ Opinions of Receipt of Clinical Care and Participation in Clinical Research at Place of Employment
Academic medical centers conduct clinical research and provide patient care to the community and their workforce. Conflict may exist, as employees might expect benefits or feel pressured or coerced to participate in research studies or receive clinical care. Without evidence, some universities consider employees to be part of a vulnerable population for research consent at their institution, potentially restricting opportunities for employees to participate in clinical trials. At the same time, these universities encourage employees to receive health care at the same institution. We hypothesized that attitudes toward voluntary research participation and receipt of health care services at the site of employment are similar and favorable. To study this, we conducted a survey of employees at Oregon Health & Science University (OHSU) that asked parallel questions focusing on attitudes regarding concerns with participation in research and receipt of clinical care. We found the majority of respondents reported favorable and similar attitudes regarding employee participation in clinical care 596/688 (87%) or research 605/639 (95%) and personally comfortable with the idea (614/688 (90%) for clinical care, 582/639 (92%) for research participation). Our findings support efforts to remove barriers that restrict participation in clinical research by employees at academic medical centers.
- 23 October 2021
- Published by Taylor & Francis in Accountability in Research
- Vol. 30 (6) , 343-355
OHSU Employees’ Opinions of Receipt of Clinical Care and Participation in Clinical Research at Place of Employment
Academic medical centers conduct clinical research and provide patient care to the community and their workforce. Conflict may exist, as employees might expect benefits or feel pressured or coerced to participate in research studies or receive clinical care. Without evidence, some universities consider employees to be part of a vulnerable population for research consent at their institution, potentially restricting opportunities for employees to participate in clinical trials. At the same time, these universities encourage employees to receive health care at the same institution. We hypothesized that attitudes toward voluntary research participation and receipt of health care services at the site of employment are similar and favorable. To study this, we conducted a survey of employees at Oregon Health & Science University (OHSU) that asked parallel questions focusing on attitudes regarding concerns with participation in research and receipt of clinical care. We found the majority of respondents reported favorable and similar attitudes regarding employee participation in clinical care 596/688 (87%) or research 605/639 (95%) and personally comfortable with the idea (614/688 (90%) for clinical care, 582/639 (92%) for research participation). Our findings support efforts to remove barriers that restrict participation in clinical research by employees at academic medical centers.